Hello! I've a request for help in evaluating a dividend-paying company.Google Alerts tipped me off to something interesting:Altana AG has sold its pharma business, and will be distributing the proceeds as a special dividend in May. Quoting: "Altana has announced a total dividend of €34.8 per share, consisting of a special dividend of €33 per share, an ordinary dividend of €1.3 per share and a bonus dividend of €0.5 per share."Current share price is about €48. Backing out the pharma business, we see EBITDA of:2006: €1862005: €1242004: €1202003: €1012003: €109Sales were up 58% in the first 9 months of 2006 due to acquisition. I'm having a tough time straightening all the numbers out--pulling out the Pharma stuff and just looking at the chemical business. The thing that's interesting to me is--by returning the money to shareholders, ROE will be unshackled. As ROE strengthens, the share price should perform well with what looks like a strong business underlying it. The Q3 report indicates that for Q1-3 2006, earnings were 2.98, with 2.50 of that being from discontinued ops (pharma.) So .48/share, compared with .28/share in the previous year's period.The basic, sloppy haven't-done-my-DD-properly thesis is: Buy the stock before it goes ex-div. Pull out the 72% dividend. Company should go to €14ish/share, if we just back the dividend out of the share price. With ROE free to grow, we should see the company's shares advance with its growth; but not rapidly.The company forecasts growth of about 6% annually, and has a long history of raising the dividend. Growth rate over 5 years is 20%. Can anyone suggest how to look at this?
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra